NCT07483983: Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 25 Mar 2026
- Primary completion
- Sep 2027
- Arms
- Cohort NSCLC, Cohort PDAC
- Results
- None posted
- 19 Mar 2026: Trial registered
- 25 Mar 2026: Trial started